Ovary removal in BRCA1 carriers cuts breast cancer risk
This article was originally published in Clinica
Women who carry the BRCA1 breast cancer gene mutation could reduce their risk of developing the disease by 70% if they have both their ovaries removed, according to a US study.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.